Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of beta-blockers and other cardiovascular drugs. Its structure allows for easy functionalization, making it valuable in creating active pharmaceutical ingredients (APIs) with targeted biological activity. Commonly employed in organic synthesis to introduce the 2,3-dihydrobenzofuran moiety, which is found in compounds with antioxidant, anti-inflammatory, and neuroprotective properties. Also utilized in research settings for the preparation of novel drug candidates and in the optimization of synthetic routes requiring brominated ketone building blocks.